GSK has agreed to pay up to $2.2 billion to settle most lawsuits in U.S. state courts claiming that a discontinued version of the heartburn drug Zantac caused cancer, the company announced on ...

GSK announced that it agreed to settle these suits for up to $2.2 billion, ... a federal judge dismissed around 50,000 Zantac lawsuits after rejecting the plaintiffs’ scientific experts.

GlaxoSmithKline has agreed to pay up to $2.2 billion to settle 80,000 Zantac lawsuits. Wednesday's announcement resolves 93% of all Zantac cases in state courts against GSK.

The Pfizer settlements come as GSK, a previous Zantac manufacturer, defends itself in an ongoing trial, while Sanofi, which recalled the drug in 2019 over cancer claims, agreed to pay more than ...

Pfizer has agreed to settle more than 10,000 lawsuits which alleged that the company failed to warn patients about possible cancer risks caused by the anti-heartburn medication Zantac.. The ...

(Reuters) -GSK has agreed to pay up to $2.2 billion to settle most lawsuits in U.S. state courts claiming that a discontinued version of the heartburn drug Zantac caused cancer, the company ...

GSK has reached agreements with 10 plaintiff firms to settle around 80,000 state court product liability cases related to its heartburn medication, Zantac, for $2.2 billion. The agreements involve ...